Europe Sepsis Diagnostics Market Size & Outlook, 2022-2030
Europe sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Europe sepsis diagnostics market highlights
- The Europe sepsis diagnostics market generated a revenue of USD 278.6 million in 2022.
- The market is expected to grow at a CAGR of 6.7% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 278.6 million |
| Market revenue in 2030 | USD 466.9 million |
| Growth rate | 6.7% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.8% of the global sepsis diagnostics market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 431.0 million by 2030.
Blood culture media was the largest segment with a revenue share of 38.94% in 2022. Horizon Databook has segmented the Europe sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
Europe accounted for the fastest CAGR of 27.5% during the forecast period. The rising incidence of sepsis, the increasing availability of innovative diagnostic technologies, and the growing demand for rapid & accurate sepsis diagnosis in clinical settings are expected to be major factors supporting market growth.
Of these, 700,000 do not survive the acute phase of the condition, and approximately one-third of those who do survive face mortality within the subsequent year. Furthermore, many sepsis survivors endure long-term effects, which can include ongoing physical disabilities, mental health challenges, and cognitive impairments.
These enduring consequences highlight the critical need for improved sepsis management and support for affected individuals in Europe. The increasing incidence of HAIs in the region highlights the urgent need for early sepsis diagnosis.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe sepsis diagnostics market size, by country, 2018-2030 (US$M)
Europe Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
